Australian Therapeutic Pipeline to translate health discoveries into clinical application

Friday, 08 August, 2014

Therapeutic Innovation Australia (TIA) has launched the Australian Therapeutic Pipeline - a collaborative initiative to better enable Australian researchers to translate their health discoveries into clinical application. The initiative was launched by Ditta Zizi, branch manager, Research and Higher Education Infrastructure of the Australian Government Department of Education, as part of TIA’s 2nd National Translational Health Capability Symposium in Brisbane.

Australia produces almost twice the amount of citeable research per capita as the United States, yet we also have one of the lowest rates in conversion of these discoveries into patents and limited success in bringing new treatments through to patients. Reasons for this poor productivity are said to relate to a lack of connectivity and commercial expertise.

The Australian Therapeutic Pipeline will consist of state-of-the-art facilities that support therapeutic product development. The pipeline will provide pathways for researchers developing new biopharmaceuticals, cell therapies, diagnostics and personalised medicines. It will also interact with TIA’s expert ‘Virtual Pharma’ committee, which will provide commercial expertise freely to Australian public sector researchers.

TIA’s translational health consortium will form the core of the pipeline, and TIA welcomes contact from other organisations providing high-quality translational research infrastructure. For more information, contact TIA CEO Dr Stewart Hay at stewart.hay@therapeuticinnovation.com.au or phone 0428 658 282.

Related News

Curiox Biosystems sues BD and Waters for NDA breach

Curiox Biosystems has filed a lawsuit against BD and Waters Corporation for trade secret...

Australia signs Horizon Europe agreement in landmark deal

The agreement provides Australian researchers and organisations with access to Horizon Europe...

Suspicious citation numbers found in high-impact journals

The likely manipulation of citation numbers by research paper mills in high-impact cancer...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd